Changing Risk Behaviours and the HIV Epidemic: A Mathematical Analysis in the Context of Treatment as Prevention

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ramadanovic, Bojan ^a   Vasarhelyi, Krisztina ^a,b   Nadaf, Ali ^a   Wittenberg, Ralf W ^a   Montaner, Julio S G ^b,c   Wood, Evan ^b,c   Rutherford, Alexander R ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CANADA; COMPARTMENT MODEL; DISEASE ELIMINATION; EPIDEMIC; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MATHEMATICAL ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; PREVALENCE; RISK REDUCTION;

ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRITISH COLUMBIA; EPIDEMICS; HIV INFECTIONS; INCIDENCE; MODELS, STATISTICAL; PREVALENCE; RISK-TAKING;

EID: 84877094186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062321     Document Type: Article

References (78)

1. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, et al. (2001) Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicine 135: 17-26.
2. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, et al. (2006) Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes 43: 27-34.
3. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine 342: 921-929.
4. Hosseinipour M, Cohen MS, Vernazza PL, Kashuba ADM, (2002) Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clinical Infectious Diseases 34: 1391-1395.
5. Attia S, Egger M, Müller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397-404.
6. Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536.
7. UNAIDS (2011) The Treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. Technical report, UNAIDS.
8. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. (2010) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PloS One 5: e11068.
9. Wood E, Kerr T, Marshall BDL, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. British Medical Journal 338: b1649.
10. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine 365: 493-505.
11. Williams B, Wood R, Dukay V, Delva W, Ginsburg D, et al. (2011) Treatment as prevention: preparing the way. Journal of the International AIDS Society 14: 56.
12. Velasco-Hernandez JX, Gershengorn HB, Blower SM, (2002) Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infectious Diseases 2: 487-493.
13. Cock KMD, Crowley SP, Lo YR, Granich RM, Williams BG, (2009) Preventing HIV transmission with antiretrovirals. Bulletin of the World Health Organization 87: 488.
14. Dieffenbach CW, Fauci AS, (2009) Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 301: 2380-2382.
15. Granich RM, Gilks CF, Dye C, Cock KMD, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
16. Nguyen VK, Bajos N, Dubois-Arber F, O'Malley J, Pirkle CM, (2011) Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention. AIDS 25: 291-293.
17. Cassell MM, Halperin DT, Shelton JD, Stanton D, (2006) Risk compensation: the Achilles' heel of innovations in HIV prevention? British Medical Journal 332: 605-607.
18. Venkatesh KK, Flanigan TP, Mayer KH, (2011) Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS 25: 1939-1949.
19. Crepaz N, Hart TA, Marks G, (2004) Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA 292: 224-236.
20. Dodds JP, Nardone A, Mercey DE, Johnson AM, Aly N, et al. (2000) Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. British Medical Journal 320: 1510-1511.
21. Miller M, Meyer L, Boufassa F, Persoz A, Sarr A, et al. (2000) Sexual behavior changes and protease inhibitor therapy. AIDS 14: F33-F39.
22. Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope BA, (2000) Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychology 19: 134-145.
23. Do AN, Hanson DL, Dworkin MS, Jones JL, (2001) the Adult and Adolescent Spectrum of HIV Disease Project (2001) Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States. AIDS 15: 1149-1155.
24. Huebner DM, Gerend MA, (2001) The relation between beliefs about drug treatments for HIV and sexual risk behavior in gay and bisexual men. Annals of Behavioral Medicine 23: 304-312.
25. Scheer S, Chu PL, Klausner JD, Katz MH, Schwarcz SK, (2001) Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 357: 432-435.
26. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, et al. (2002) Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS 16: 775-780.
27. Halkitis PN, Zade DD, Shrem M, Marmor M, (2004) Beliefs about HIV non-infection and risky sexual behavior among MSM. AIDS Education and Prevention 16: 448-458.
28. Stolte IGD, Wit JBFD, Eeden AV, Coutinho RA, Dukers NHTM, (2004) Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS 19: 1043-1049.
29. Schwarcz S, Scheer S, Mcfarland W, Katz M, Valleroy L, et al. (2007) Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. American Journal of Public Health 97: 1067-1075.
30. Sullivan PS, Drake AJ, Sanchez TH, (2007) Prevalence of treatment optimism-related risk behavior and associated factors among men who have sex with men in 11 states, 2000-2001. AIDS and Behavior 11: 123-129.
31. Truong MHH, Kellogg T, Klausner JD, Katz MH, Dilley J, et al. (2006) Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sexually Transmitted Infections 82: 461-466.
32. Bezemer D, Wolf FD, Boerlijst MC, Sighem AV, Hollingsworth TD, et al. (2008) A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 22: 1071-1077.
33. Joseph HA, Flores SA, Parsons JT, Purcell DW, (2010) Beliefs about transmission risk and vulnerability, treatment adherence, and sexual risk behavior among a sample of HIV-positive men who have sex with men. AIDS Care 22: 29-39.
34. Remien RH, Halkitis PN, O'Leary A, Wolitski RJ, Gómez CA, (2005) Risk perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS and Behavior 9: 167-176.
35. Stephenson JM, Imrie J, Davis MMD, (2003) Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection? Sexually Transmitted Infections 79: 7-10.
36. Bunnell R, Paul J, Solberg P, Wamai N, Bikaako-Kajura W, et al. (2006) Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20: 85-92.
37. Sarna A, Luchters SMF, Geibel S, Kaai S, Munyao P, et al. (2008) Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. International Journal of STD & AIDS 19: 85-89.
38. Kalichman SC, Eaton L, Cain D, Cherry C, Pope H, et al. (2006) HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women. Journal of Behavioral Medicine 29: 401-410.
39. Lindenburg CEA, Krol A, Smit C, Buster CA, Coutinho RA, et al. (2006) Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 20: 1771-1775.
40. Smit C, Lindenburg K, Geskus RB, Brinkman K, Coutinho RA, et al. (2006) Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. Addiction 101: 433-440.
41. Bouhnik AD, Moatti JT, Vlahov D, Gallais H, Dellamonica P, et al. (2002) Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. Journal of Epidemiology and Community Health 56: 349-353.
42. Blower SM, Gershengorn HB, Grant RM, (2000) A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287: 650-654.
43. Dangerfield BC, Fang Y, Roberts CA, (2001) Model-based scenarios for the epidemiology of HIV/AIDS: the consequences of highly active antiretroviral therapy. System Dynamics Review 17: 119-150.
44. Law MG, Prestage G, Grulich A, Van De Ven P, Kippax S, (2001) Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 15: 1287-1294.
45. Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951.
46. Salomon JA, Hogan DR, (2008) Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 22: S149-S159.
47. Lou J, Wu J, Chen L, Ruan Y, Shao Y, (2009) A sex-role-preference model for HIV transmission among men who have sex with men in China. BMC Public Health 75: 213-221.
48. Adam B, (2011) Epistemic fault lines in biomedical and social approaches to HIV prevention. Journal of the International AIDS Society 14Supplement 2: 52.
49. Huebner DM, Rebchook GM, Kegeles SM, (2004) A longitudinal study of the association between treatment optimism and sexual risk behaviour in young adult gay and bisexual men. Journal of Acquired Immune Deficiency Syndromes 37: 1514-1519.
50. Auld MC, (2002) Choices, beliefs, and infectious disease dynamics. Journal of Health Economics 22: 361-377.
51. Scherer CW, Cho H, (2003) A social network contagion theory of risk perception. Risk Analysis 23: 261-267.
52. Scherer CW, Cho H, (2008) Social networks and health. Annual Reviews of Sociology 34: 405-429.
53. Blyuss K, Kyrychko YN, (2005) On a basic model of a two-disease epidemic. Applied Mathematics and Computation 160: 177-187.
54. Li J, Wang L, Zhao H, Ma Z, (2008) Dynamical behavior of an epidemic model with coinfection of two diseases. Rocky Mountain Journal of Mathematics 38: 1457-1479.
55. Massad E, Burattini MN, Coutinho FAB, Yang HM, Raimundo SM, (1993) Modeling the interaction between AIDS and tuberculosis. Mathematical and Computer Modelling 27: 7-21.
56. Kirschner D, (1999) Dynamics of co-infection with M. Tuberculosis and HIV-1. Theoretical Population Biology 55: 94-109.
57. Chowell-Puente D, Jiménez-González B, Smith AN, Rios-Soto K, Song B (2007) The cursed duet: Dynamics of HIV-TB co-infection in South Africa. Mathematical and Theoretical Biology Institute Reports MTBI-04-08M.
58. Bauer AL, Hogue IB, Marino S, Kirschner DE, (2008) The effects of HIV-1 infection on latent tuberculosis. Mathematical Modelling of Natural Phenomena 3: 229-266.
59. Bacaer N, Ouifki R, Pretorius C, Wood R, Williams B, (2008) Modeling the joint epidemics of TB and HIV in a South African township. Journal of Mathematical Biology 57: 557-93.
60. Sharomi O, Podder CN, Gumel AB, (2008) Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment. Mathematical Biosciences and Engineering 5: 145-174.
61. Bhunu CP, Garira W, Mukandavire Z, (2009) Modeling HIV/AIDS and tuberculosis coinfection. Bulletin of Mathematical Biology 71: 145-174.
62. Long EF, Vaidya NK, Brandeau ML, (2009) Controlling co-epidemics: Analysis of HIV and tuberculosis infection dynamics. Operations Research 56: 1366-1381.
63. Roeger LI, Feng Z, Castillo-Chavez C, (2009) Modeling TB and HIV co-infections. Mathematical Biosciences and Engineering 6: 815-837.
64. Sorathiya A, Bracciali A, Liò P, (2010) Formal reasoning on qualitative models of coinfection of HIV and tuberculosis and HAART therapy. BMC Bioinformatics 11: 567.
65. Kault DA, (1992) Modelling the effects of AIDS on gonorrhoea epidemiology. Mathematical and Computer Modelling 16: 3-14.
66. Mushayabasa S, Tchuenche JM, Bhunu C, Ngarakana-Gwasira E, (2011) Modeling gonorrhea and HIV co-interaction. BioSystems 103: 27-37.
67. BC-CDC (2010) HIV and sexually transmitted infections: Annual surveillance report 2010. Technical report, British Columbia Centre for Disease Control, Available: http://www.bccdc.ca/util/about/annreport/. Accessed 2011 Dec 30.
68. Wood E, Schechter MT, Tyndall MW, Montaner JSG, O'Shaughnessy MV, et al. (2000) Antiretroviral medication use among injection drug users: two potential futures. AIDS 14: 1229-1235.
69. Pinkerton S, (2008) Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS and Behavior 12: 677-684.
70. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
71. Wood E, Kerr T, Werb D, DeBeck K, Graham D, et al. (2009) Drug situation in Vancouver. Technical report, Addiction and Urban Health Research Initiative, Available: http:uhri.cfenet.ubc.ca/images/Documents/dsiv2009.pdf. Accessed 2011 Dec 30.
72. Kerr T, Small W, Buchner C, Zhang R, Li K, et al. (2010) Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. American Journal of Public Health 100: 1449-1453.
73. Marshall BDL, Milloy MJ, Kerr T, Zhang R, Montaner JSG, et al. (2010) No evidence for increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs. AIDS 24: 2271-2278.
74. Strathdee SA, Stockman JK, (2010) Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Current HIV/AIDS Reports 7: 99-106.
75. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollingsworth TD, et al. (2010) 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysis. Epidemics 2: 66-79.
76. Couzin J, (2009) Friendship as a health factor. Science 323: 454-457.
77. Gill VS, Lima VD, Zhang W, Wynhoven B, Yip B, et al. (2010) Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV Type 1 drug resistance detection. Clinical Infectious Diseases 50: 98-105.
78. Raboud J, Boily M, Rajeswaran J, O'Shaughnessy M, Schechter M, (2003) The impact of needleexchange programs on the spread of HIV among injection drug users: A simulation study. Journal of Urban Health 80: 302-320.